Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05770037
Title DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Teenage/Young Adults (TYA) and Paediatric Patients With ALK Positive Cancers (DETERMINE)
Acronym DETERMINE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Cancer Research UK
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries GBR

Additional content available in CKB BOOST